Lifecore Biomedical
LFCR
99 hedge funds and large institutions have $342M invested in Lifecore Biomedical in 2015 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 27 increasing their positions, 42 reducing their positions, and 15 closing their positions.
513% more call options, than puts
Call options by funds: $282K | Put options by funds: $46K
1% more capital invested
Capital invested by funds: $338M → $342M (+$3.26M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
9% less funds holding
Funds holding: 109 → 99 (-10)
36% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 42
67% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$3.16M |
| 2 |
NIMC
NWQ Investment Management Company
Los Angeles,
California
|
+$2.56M |
| 3 |
Boston Partners
Boston,
Massachusetts
|
+$2.33M |
| 4 |
RA
Royce & Associates
New York
|
+$1.38M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$1.21M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$2.02M |
| 2 |
Morgan Stanley
New York
|
-$1.64M |
| 3 |
OCG
Opus Capital Group
Cincinnati,
Ohio
|
-$1.45M |
| 4 |
KG
Killen Group
Berwyn,
Pennsylvania
|
-$1.38M |
| 5 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$1.25M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACH
101
ArrowMark Colorado Holdings
Denver,
Colorado
| – | -$1.14M | -82,379 | Closed |
|
102
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$292K | -21,143 | Closed |
|
103
Millennium Management
New York
| – | -$285K | -20,660 | Closed |
|
|
OAM
104
Oxford Asset Management
Oxford,
United Kingdom
| – | -$223K | -15,799 | Closed |
|
|
DTL
105
Dynamic Technology Lab
Singapore
| – | -$206K | -14,951 | Closed |
|
|
CCM
106
Coldstream Capital Management
Bellevue,
Washington
| – | -$203K | -14,735 | Closed |
|
107
SG Americas Securities
New York
| – | -$125K | -9,016 | Closed |
|
108
Norges Bank
Oslo,
Norway
| – | -$81K | -5,892 | Closed |
|
109
Acadian Asset Management
Boston,
Massachusetts
| – | -$42K | -3,050 | Closed |
|
110
Envestnet Asset Management
Chicago,
Illinois
| – | -$28K | -1,992 | Closed |
|
111
Group One Trading
Chicago,
Illinois
| – | -$21K | -1,500 | Closed |
|
|
RC
112
RegentAtlantic Capital
Morristown,
New Jersey
| – | -$13.8K | -1,000 | Closed |
|
113
Parallax Volatility Advisers
San Francisco,
California
| – | -$3K | -231 | Closed |
|
LFCR Hedge Fund Activity: Q1 2015 in Review
99 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Lifecore Biomedical (LFCR) for Q1 2015, worth a combined $342M — up 0.96% from $338M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of LFCR and 5 opened new positions — a net loss of 10 holders — while 42 trimmed existing stakes and 27 added.
The largest buyer was Royal Bank of Canada, adding an estimated $3.16M. The largest seller was Guggenheim Capital, cutting an estimated $2.02M.
- 99 institutional investors held Lifecore Biomedical (LFCR) as of Q1 2015, down from 109 in Q4 2014.
- Funds reported $342M of Lifecore Biomedical stock for Q1 2015, up 0.96% quarter-over-quarter.
- 5 funds opened new Lifecore Biomedical positions in Q1 2015 and 15 closed out, a net change of -10 holders.
- The largest Lifecore Biomedical buyer in Q1 2015 was Royal Bank of Canada, an estimated $3.16M added.
- The largest Lifecore Biomedical seller in Q1 2015 was Guggenheim Capital, an estimated $2.02M sold.
Based on aggregated 13F filings for Q1 2015.